NCT04485052 2023-10-23Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid LeukemiaInnovent Biologics (Suzhou) Co. Ltd.Phase 1/2 Suspended222 enrolled